###begin article-title 0
###xml 79 87 <span type="species:ncbi:9606">patients</span>
Clinical relevance of the interleukin 10 promoter polymorphisms in Chinese Han patients with major trauma: genetic association studies
###end article-title 0
###begin title 1
Introduction
###end title 1
###begin p 2
###xml 364 372 <span type="species:ncbi:9606">patients</span>
An excessive inflammatory response is thought to account for the pathogenesis of sepsis and multiple organ dysfunction syndrome (MODS) after severe trauma. The interleukin-10 (IL-10) is a potent anti-inflammatory cytokine. The objectives of this prospective study were to investigate the distribution of IL-10 promoter polymorphisms in a cohort of 308 Chinese Han patients with major trauma, and to identify associations of IL-10 promoter polymorphisms with IL-10 production and incidence of sepsis and MODS.
###end p 2
###begin title 3
Methods
###end title 3
###begin p 4
###xml 15 23 <span type="species:ncbi:9606">patients</span>
A total of 308 patients with major trauma were included in this study. The genotypes of polymorphisms -1082, -819 and -592 were determined by polymerase chain reaction-restriction fragment length polymorphism. The IL-10 levels in the supernatants were determined with enzyme-linked immunoabsorbent assay.
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
The -1082A and -592A alleles were significantly associated with lower lipopolysaccharide-induced IL-10 production in an allele-dose dependent fashion. There was no significant difference for the -819 polymorphism. Except for the -1082 polymorphism, the -819 and -592 polymorphisms were not significantly associated with sepsis morbidity rate and MOD scores.
###end p 6
###begin title 7
Conclusions
###end title 7
###begin p 8
###xml 208 216 <span type="species:ncbi:9606">patients</span>
Our results further confirm the functionality of the IL-10 promoter single nucleotide polymorphisms in relation to IL-10 production. They also suggest that individual difference in IL-10 production in trauma patients might be at least in part related to genetic variations in the IL-10 promoter region.
###end p 8
###begin title 9
Introduction
###end title 9
###begin p 10
###xml 112 113 112 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 290 291 290 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 612 613 612 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 614 615 614 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 854 855 854 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 856 857 856 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 397 405 <span type="species:ncbi:9606">patients</span>
###xml 602 610 <span type="species:ncbi:9606">patients</span>
###xml 844 852 <span type="species:ncbi:9606">patients</span>
###xml 1080 1088 <span type="species:ncbi:9606">patients</span>
Trauma, a major public health problem worldwide, ranks as the fourth leading cause of death among all diseases [1]. One of the most serious complications of major trauma is the sequential dysfunction of vital organs, which is associated with post-traumatic sepsis in the majority of cases [2]. Therefore, preventing sepsis and subsequent organ dysfunction is crucial in the treatment of surviving patients with major trauma. It has been demonstrated that inappropriate immune inflammatory response contributes to the development of sepsis and multiple organ dysfunction syndrome (MODS) in major trauma patients [3,4]. Increasing evidence suggests that genetic variants, particularly single nucleotide polymorphisms (SNPs), are critical determinants for inter-individual differences in both inflammatory responses and clinical outcome in trauma patients [5,6]. Delineating the variation in genes and associated differences in response to trauma may contribute to the development of new genetically tailored diagnostic and therapeutic interventions that will improve outcome in the patients with major trauma.
###end p 10
###begin p 11
###xml 240 241 232 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 292 293 284 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 421 426 413 418 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(-/-)</sup>
###xml 572 577 564 569 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(-/-)</sup>
###xml 589 590 581 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 787 789 779 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 888 890 880 882 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 891 893 883 885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 1075 1077 1067 1069 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 1078 1080 1070 1072 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 1249 1251 1241 1243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 1452 1454 1444 1446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 1558 1560 1550 1552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 1705 1707 1697 1699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 1725 1727 1717 1719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 1741 1743 1733 1735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 1761 1763 1753 1755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 1787 1789 1779 1781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 1829 1831 1821 1823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 1845 1847 1837 1839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 2070 2072 2062 2064 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 2073 2075 2065 2067 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 2104 2106 2096 2098 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 2107 2109 2099 2101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 432 436 <span type="species:ncbi:10090">mice</span>
###xml 583 587 <span type="species:ncbi:10090">mice</span>
###xml 860 868 <span type="species:ncbi:9606">patients</span>
###xml 2247 2255 <span type="species:ncbi:9606">patients</span>
IL-10 is one of the key anti-inflammatory cytokines and it decreases the production of inflammatory molecules, such as TNF-alpha, interferon (IFN)-gamma, IL-12, reactive nitric oxide metabolites, major histocompatibility complex molecules [7] and inhibits antigen-specific cytotoxic T cells [8]. The magnitude of the proinflammatory cytokine response, neutrophil infiltration, and injury were shown to be greater in IL-10(-/-)-null mice after visceral ischemia-reperfusion injury. Administration of exogenous IL-10 results in a decrease in neutrophil infiltration in IL-10(-/-)-null mice [9]. It suggests that lower producers of IL-10 might be sensitive to the development of sepsis and MODS due to its ability to suppress inflammation. IL-10 has been shown to be elevated after trauma [10] and is well correlated with the development of sepsis and outcome in patients with major trauma [11,12]. Previous studies have demonstrated that the variation in IL-10 production is largely genetically determined, which is mainly related to genetic variations in the promoter region [13,14]. The IL-10 5'-flanking region, which controls transcription, is polymorphic, with two microsatellites between -4000 and -1100, and three SNPs (-1082, -819, and -592) [15]. The -1082, -819 and -592 polymorphisms are shown to be in close linkage disequilibrium and construct only three haplotypes in the white population (GCC, ACC and ATA in an order of -1089/-819/-592) [16]. These haplotypes are associated with high (GCC), intermediate (ACC), and low (ATA) IL-10 production [14]. Genetic association studies have indicated that the three SNPs in the IL-10 promoter are linked to various diseases, such as Crohn's disease [16], schizophrenia [17], hepatitis [18], endometriosis [19], Alzheimer's disease [20], acute respiratory distress syndrome [21] and sepsis [22]. However, clinical relevance of the three SNPs is still not fully understood, due to considerable controversy in the literature regarding the influence of these SNPs on susceptibility to diseases and their functionality [23-25]. Schroeder and colleagues [23,26] reported the association of the IL-10 with the -1082 and -592 polymorphisms with the incidence of MODS and acute respiratory failure in patients with major trauma, respectively, and also showed inconsistent results.
###end p 11
###begin p 12
In this study we investigated whether the genetic variations at positions -1082, -819 and -592 in the IL-10 promoter affect IL-10 production after trauma, and whether there is an association of these polymorphisms with the development of post-traumatic sepsis and MODS. Our hypothesis was that genetically determined lower production of IL-10 might increase susceptibility to post-traumatic complications.
###end p 12
###begin title 13
Materials and methods
###end title 13
###begin title 14
Study population
###end title 14
###begin p 15
###xml 960 962 960 962 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 15 23 <span type="species:ncbi:9606">patients</span>
###xml 175 183 <span type="species:ncbi:9606">patients</span>
###xml 707 715 <span type="species:ncbi:9606">Patients</span>
###xml 969 977 <span type="species:ncbi:9606">patients</span>
###xml 1262 1270 <span type="species:ncbi:9606">patients</span>
###xml 1278 1285 <span type="species:ncbi:9606">patient</span>
A total of 308 patients with major trauma (240 male and 68 female) were prospectively recruited in this study. All of them are Han Chinese and live in Chongqing district. The patients were consecutively admitted to the Department of Trauma Surgery in the Daping Hospital and the Chongqing Emergency Medical Center between 1 January, 2005 and 1 June, 2008. They were enrolled in the study if they met the following criteria: (1) aged between 18 and 65 years; (2) expected Injury Severity Score (ISS) greater than 16 combined with the presence of at least one life-threatening injury and at least one additional severe injury in another part of the body and (3) probability of survival greater than 48 hours. Patients were not eligible if they had penetrating injuries, or pre-existing cardiovascular, respiratory, renal, hepatic, hematologic or immunological diseases. ISS was performed according to the Abbreviated Injury Scale 2005 by independent evaluators [27]. All patients requiring surgical intervention received standard surgical care and postoperative intensive care unit treatment. The protocol for this study was approved by the Ethical and Protocol Review Committee of the Third Military Medical University, and informed consent was obtained from the patients or the patient's next of kin.
###end p 15
###begin title 16
Genotyping of the IL-10 promoter polymorphisms
###end title 16
###begin p 17
###xml 592 593 592 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
###xml 106 114 <span type="species:ncbi:9606">patients</span>
Blood specimens were collected in tripotassium ethylenediamine tetraacetic acid sterile tubes from trauma patients immediately after admission (generally within 10 hours after injury) in order to avoid the effect of blood transfusion. The genomic DNA was isolated from whole blood using Wizard genomic DNA purification kit (Promega, Madison, WI, USA) according to the manufacturer's protocol. A PCR-restriction fragment length polymorphism (RFLP) method was used to detect the IL-10 promoter polymorphisms. The oligonucleotide primers for amplification and PCR conditions were shown in Table 1. PCR products were digested with XagI, Hin1alpha or Rsa I (New England Biolabs, Beverly, MA, USA) for one hours at 37degreesC. The SNPs were then genotyped by fragment size obtained after agarose gel electrophoresis, which were further confirmed by DNA sequencing of the IL-10 promoter with 10 random samples (Takara Biotech, Dalian, China). The genotyping was performed in a blinded fashion such that those analyzing the genotype data did not know any other experimental results.
###end p 17
###begin p 18
Primers and endonucleases for genotyping of IL-10 promoter single nucleotide polymorphisms
###end p 18
###begin title 19
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ex vivo </italic>
Ex vivo IL-10 production
###end title 19
###begin p 20
###xml 60 61 60 61 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 268 285 268 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli </italic>
###xml 2 7 <span type="species:ncbi:9606">human</span>
###xml 124 132 <span type="species:ncbi:9606">patients</span>
###xml 268 288 <span type="species:ncbi:404399">Escherichia coli O26</span>
A human whole-blood assay was used as described previously [6]. In brief, aliquots of whole blood collected from the trauma patients were mixed in a ratio of 1:1 with Roosevelt Park Memorial Institute medium 1640, and incubated with 100 ng/ml lipopolysaccharide (LPS; Escherichia coli O26:B6, Difco Laboratories, Detroit, MI, USA) in a sample mixer at 37degreesC for four hours. The supernatants were then separated by centrifugation. The IL-10 levels in the supernatants were determined by ELISA according to the manufacturer's instructions (R & D System, Minneapolis, MN, USA). The lower limit for detection was 4 pg/ml. Variability between triplicate wells was less than 5%.
###end p 20
###begin title 21
Clinical evaluation
###end title 21
###begin p 22
###xml 423 425 423 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 782 783 770 771 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">9</sup>
###xml 805 806 793 794 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">9</sup>
###xml 21 29 <span type="species:ncbi:9606">patients</span>
###xml 556 563 <span type="species:ncbi:9606">patient</span>
###xml 599 607 <span type="species:ncbi:9606">patients</span>
After admission, the patients with major trauma were monitored in the following aspects: respiratory (partial pressure of arterial oxygen/fraction of inspired oxygen ratio), renal (serum creatinine concentration), hepatic (serum bilirubin concentration), cardiovascular (pressure-adjusted heart rate) and hematologic (platelet count) systems. The organ function was then scored using the method of Marshall and colleagues [28] and calculated as a single daily value during the intensive care unit stay. Neurological scoring was not performed because every patient was sedated. Sepsis was defined if patients met all the following criteria: clinical evidence of infection, body temperature greater than 38.5degreesC or less than 36.5degreesC, and leukocyte count greater than 10 x 109/L or less than 4 x 109/L. The MODS scores and sepsis were determined by individuals who did not know the genotypes.
###end p 22
###begin title 23
Statistical analysis
###end title 23
###begin p 24
###xml 80 82 80 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
Sample size was calculated using online Power and Sample Size Program software [29]. The desired power of our study was set at 80% with a significance level of 0.05 in a two-sided test. We chose the log-additive inheritance model, which is the most suitable for polygenic diseases. By means of the Power and Sample Size program, our sample (n = 308) was considered adequate to study the -1082, -819 and -592 polymorphisms.
###end p 24
###begin p 25
###xml 825 827 825 827 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 308 316 <span type="species:ncbi:9606">patients</span>
Allele frequencies for each SNP were determined by gene counting. Any deviation from Hardy-Weinberg equilibrium was calculated by a chi-squared goodness-of-fit test. The chi-squared test or Fisher's exact test was used to determine differences in frequencies of the IL-10 promoter polymorphisms among trauma patients with different genotypes. Odds ratios (OR) and 95% confidence intervals (CI) were calculated using logistic regression models whenever that chi-squared or Fisher's exact test was significant. The association of the IL-10 promoter polymorphisms with plasma IL-10 levels and MODS scores was determined using one-way analysis of variance. Three genetic models (allele-dose, dominant, and recessive) were used. Significant probability values obtained were corrected for multiple testing (Bonferroni correction). P values less than 0.05 were considered significant. All statistic analysis was carried out using SPSS Version 11.0 (SPSS Inc, Chicago, Illinois, USA).
###end p 25
###begin title 26
Results
###end title 26
###begin title 27
###xml 36 44 <span type="species:ncbi:9606">patients</span>
Overall clinical characteristics of patients with major trauma
###end title 27
###begin p 28
###xml 250 251 250 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">2</xref>
###xml 4 11 <span type="species:ncbi:9606">patient</span>
###xml 68 76 <span type="species:ncbi:9606">patients</span>
###xml 222 230 <span type="species:ncbi:9606">patients</span>
###xml 274 282 <span type="species:ncbi:9606">patients</span>
###xml 376 384 <span type="species:ncbi:9606">patients</span>
###xml 446 454 <span type="species:ncbi:9606">patients</span>
###xml 647 654 <span type="species:ncbi:9606">patient</span>
###xml 740 747 <span type="species:ncbi:9606">patient</span>
###xml 781 789 <span type="species:ncbi:9606">patients</span>
The patient cohort comprised a total of 308 consecutive Han Chinese patients with severe multiple trauma. Trauma was caused by traffic accidents (n = 187), falling (n = 105), or other causes (n = 16). Baseline data of the patients are shown in Table 2. The severely injured patients (mean ISS 25.5 +/- 8.2) were mostly young (38.5 +/- 11.5 years). One hundred and forty seven patients (47.7%) developed sepsis. Two hundred and fifty five (82.8%) patients developed organ dysfunction, among whom one hundred and sixty (52%) had two or more organ dysfunctions. The mean time to MODS was 4.4 +/- 3.5 days. The mean number of operations performed per patient was 3.5 +/- 3.2 (range 1 to 14). Substitution of erythrocytes was necessary in every patient (mean 5.4 +/- 5.2 L). All of the patients survived at least 48 hours after admission and completed genotyping.
###end p 28
###begin p 29
###xml 36 44 <span type="species:ncbi:9606">patients</span>
Overall clinical characteristics of patients with major trauma (n = 308)
###end p 29
###begin p 30
AIS = Abbreviated Injury Scale; ISS = Injury Severity Scores.
###end p 30
###begin title 31
Allele frequencies and genotype distribution
###end title 31
###begin p 32
###xml 239 240 239 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">3</xref>
###xml 588 596 <span type="species:ncbi:9606">patients</span>
The overall minor allele frequencies were 15.4%, 29.2% and 34% for the -1082G, -819C and -592C alleles, respectively, in our cohort. The genotype frequencies of these three SNPs were in agreement with the Hardy-Weinberg equilibrium (Table 3). These SNPs were completely (-819 to -592) or strongly (-1082 to -819 and -592) linked. The three common haplotypes with frequency of more than or equal to 10% were -1082A/-819T/-592A (ATA, 49.5%), -1082A/-819T/-592C (ATC, 14.1%) and -1082A/-819C/-592A (ACA, 13.1%), respectively. With regard to the number of ATA haplotypes, 25.7% of the trauma patients had the genotype 0 ATA, 51.2% had 1 ATA, and 23.1% had 2 ATA.
###end p 32
###begin p 33
###xml 62 70 <span type="species:ncbi:9606">patients</span>
Distribution of the IL-10 promoter polymorphisms among trauma patients
###end p 33
###begin p 34
###xml 23 24 23 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 24 26 24 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 35 36 35 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 36 38 36 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
Sepsis vs. non-sepsis: aP = 0.037, bP = 0.038. HWE = Hardy-Weinberg equilibrium; MA = minor allele.
###end p 34
###begin title 35
Association of the IL-10 promoter polymorphisms with IL-10 production
###end title 35
###begin p 36
###xml 390 391 390 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T4">4</xref>
###xml 897 899 897 899 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 911 913 911 913 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 1125 1127 1125 1127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 1139 1141 1139 1141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 1351 1352 1351 1352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T4">4</xref>
###xml 1488 1489 1488 1489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T5">5</xref>
###xml 1652 1654 1652 1654 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 1800 1802 1800 1802 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 218 226 <span type="species:ncbi:9606">patients</span>
###xml 480 488 <span type="species:ncbi:9606">patients</span>
Given the possible functionality of the -1082, -819 and -592 polymorphisms, we hypothesized that these SNPs might affect IL-10 production after trauma, leading to individual difference in plasma IL-10 levels in trauma patients. Peripheral blood was taken immediately after admission in an attempt to avoid the potential effects of non-genetic factors on IL-10 production. As shown in Table 4, there were no significant differences in age, gender ratio and ISS scores among trauma patients with different genotypes of the three polymorphisms. Spontaneous IL-10 production was not significantly different between different genotypes of all three loci (data not shown). However, LPS-induced IL-10 production was shown to be significantly different between different genotypes of the -1082 and -592 polymorphisms, showing that the -1082A and -592A alleles were associated with lower IL-10 production (P = 0.005 and P = 0.001, respectively by dominant effect). Data from linear regression analysis indicated that the functional association of these two polymorphisms with IL-10 production was significantly allele-dose dependent (P = 0.003 and P = 0.037 for -1082 and -592, respectively). Although the -819T allele is also associated with lower LPS-induced IL-10 production, no significant difference was found between the different genotype groups (Table 4). In case of a combination effect of the three SNPs, we further analyzed the association of ATA haplotype with IL-10 production. Table 5 showed that the production of IL-10 was lowest in those with haplotype genotype 2 ATA, showing significant difference if compared with those with genotype 0 ATA (P = 0.041). Data from linear regression analysis indicated that this association with IL-10 production were significantly haplotype-dose dependent (P = 0.041).
###end p 36
###begin p 37
###xml 58 66 <span type="species:ncbi:9606">patients</span>
Clinical relevance of the IL-10 promoter polymorphisms in patients with major trauma
###end p 37
###begin p 38
###xml 100 102 100 102 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a1</sup>
###xml 102 104 102 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 113 115 113 115 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a2</sup>
###xml 115 117 115 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 126 128 126 128 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a3</sup>
###xml 128 130 128 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
a: dominant effect (variant homozygotes +heterozygotes vs. wild homozygotes) as analyzed by ANCOVA, a1P = 0.038, a2P = 0.005, a3P = 0.001.
###end p 38
###begin p 39
###xml 102 104 102 104 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b1</sup>
###xml 104 106 104 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 115 117 115 117 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b2</sup>
###xml 117 119 117 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
b: recessive effect (variant homozygotes vs. heterozygotes + wild homozygotes) as analyzed by ANCOVA, b1P = 0.088, b2P = 0.083.
###end p 39
###begin p 40
###xml 65 67 65 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c1</sup>
###xml 67 69 67 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 78 80 78 80 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c2</sup>
###xml 80 82 80 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
c: allele dose effect as analyzed by linear regression analysis, c1P = 0.003, c2P = 0.037.
###end p 40
###begin p 41
ANCOVA = analysis of covariance; F = female; ISS = Injury Severity Score; M = male; MOD = multiple organ dysfunction.
###end p 41
###begin p 42
###xml 64 72 <span type="species:ncbi:9606">patients</span>
Clinical relevance of Interleukin-10 haplotypes in major trauma patients
###end p 42
###begin p 43
*'0 ATA haplotype' includes the following genotypes: ATC/ATC, ATC/ACC, ACA/ACA, ACA/ACC, ACC/ACC, ATC/GTC, ATC/GCC, ACC/GTC, ACA/GCA, ACC/GCA, ACA/GCC, ACC/GCC, GTA/GTC, GTC/GTC, GTA/GCC and GTC/GCA; '1 ATA haplotype' includes ATA/ATC, ATA/ACA, ATA/ACC, ATA/GTA, ATA/GTC, ATA/GCA and ATA/GCC; '2 ATA haplotype' is ATA/ATA. haplotype is indicated in an order of -1082A, -819T and -592A.
###end p 43
###begin p 44
###xml 19 21 19 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 56 58 56 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
a: 2 ATA vs 0 ATA, P = 0.041; c: haplotype dose effect, P = 0.041.
###end p 44
###begin p 45
MODS = multiple-organ dysfunction syndrome.
###end p 45
###begin title 46
###xml 94 102 <span type="species:ncbi:9606">patients</span>
Association of the IL-10 promoter polymorphisms with development of sepsis and MODS in trauma patients
###end title 46
###begin p 47
###xml 18 19 18 19 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T4">4</xref>
###xml 196 198 196 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 431 433 431 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 575 577 575 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 126 134 <span type="species:ncbi:9606">patients</span>
###xml 532 540 <span type="species:ncbi:9606">patients</span>
###xml 753 761 <span type="species:ncbi:9606">patients</span>
As shown in Table 4, there was a close association of the -1082 polymorphism with the development of sepsis, showing that the patients with the A allele had significantly higher sepsis morbidity (P = 0.038 for dominant effect). Data from multiple logistical regression analyses indicated that A to G variation at this position was borderline significantly associated with lower risk of sepsis (OR = 0.677, 95% CI = 0.453 to 1.011, P = 0.057). In addition, there was a borderline significantly increasing trend of MODS scores in the patients with the A allele at -1082 locus (P = 0.088 for recessive effect). However, both of the -819 and -592 polymorphisms were not shown to be significantly associated with the development of sepsis and MODS in trauma patients.
###end p 47
###begin p 48
###xml 304 306 304 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 484 486 484 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 653 654 653 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">3</xref>
###xml 971 972 971 972 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T5">5</xref>
###xml 197 205 <span type="species:ncbi:9606">patients</span>
###xml 217 225 <span type="species:ncbi:9606">patients</span>
###xml 341 349 <span type="species:ncbi:9606">patients</span>
###xml 433 441 <span type="species:ncbi:9606">patients</span>
###xml 543 551 <span type="species:ncbi:9606">patients</span>
Concerning the association of sepsis with allele and genotype frequencies, there were no significant differences in allele and genotype frequencies of the three polymorphic loci between all trauma patients and trauma patients with sepsis. There was a significant difference in the AA genotype frequency (P = 0.038) at position -1082 between patients with and without sepsis. The frequency of the G allele was significantly higher in patients without sepsis than in those with sepsis (P = 0.037). No significant difference was observed between patients with and without sepsis for the allele and genotype frequencies of other two polymorphic loci (Table 3). With respect to the combination effect of the three SNPs, although there was a trend of increasing risk for sepsis incidence with the number of ATA haplotype (39.4% for 0 ATA vs 54.4% for 2 ATA), no significant differences in MODS scores and sepsis morbidity rate were observed between any haplotype groups (Table 5).
###end p 48
###begin title 49
Discussion
###end title 49
###begin p 50
###xml 324 326 324 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 327 329 327 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 330 332 330 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 363 365 363 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 452 454 452 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 455 457 455 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 458 460 458 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 461 463 461 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 560 562 560 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 563 565 563 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 566 568 566 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 569 571 569 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 729 731 729 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 732 734 732 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 735 737 735 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 738 740 738 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 741 743 741 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 781 783 781 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 784 786 784 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 1106 1108 1106 1108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 107 115 <span type="species:ncbi:9606">patients</span>
###xml 314 322 <span type="species:ncbi:9606">patients</span>
The aim of the present study was to estimate the clinical relevance of the IL-10 promoter polymorphisms in patients with major trauma. The described genotype and allele frequencies of the IL-10 polymorphisms studied in this cohort are quite similar to previously reported distributions in other studies in Chinese patients [18-20,25] and other Asian populations [30]. The minor alleles at positions -819 and -592 are the C allele in Asian populations [18-20,25,30], which is different to those seen in Western populations, being T and A alleles, respectively [22-24,26,31]. Although the minor allele at position -1082 is G in both Asian and Western populations, its frequency is quite different, over 40% in Western populations [21,22,26,31,32] and about 10% in Asian populations [19-21]. This leads to quite a difference in the common haplotypes between Asian and Western populations. Three common haplotypes in this cohort are ATA, ATC and ACA, respectively, while GCC, ATA and ACC are the common haplotypes in Western populations. The differences in allele prevalence might be due to ethnic difference [33].
###end p 50
###begin p 51
###xml 97 99 97 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 174 176 174 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 348 350 348 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 573 575 573 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 1042 1044 1042 1044 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 1045 1047 1045 1047 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 1118 1120 1118 1120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 1146 1148 1146 1148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 1604 1606 1604 1606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 1407 1415 <span type="species:ncbi:9606">patients</span>
###xml 1493 1501 <span type="species:ncbi:9606">patients</span>
###xml 1790 1798 <span type="species:ncbi:9606">patients</span>
It has been shown that about 75% of the variation in IL-10 production is genetically determined [13]. IL-10 production appears to be controlled at the transcriptional level [34]. The -1082, -819 and -592 polymorphisms have been shown to affect promoter activity, showing that the ATA haplotype is associated with the lowest transcription activity [19]. Results from bioinformatics analysis indicates that base pair substitutions at positions -1082, -819 and -592 might affect putative transcription factor binding, such as C/EBP beta, GATA-binding factor 2, Ets and STAT3 [35]. Given the functionality of the IL-10 promoter SNPs, we investigate whether these SNPs affect IL-10 production in response to a known stimulus such as LPS immediately after trauma. In the case of the effect of individual SNP, our results indicate that both of the -1082 A and -592 A alleles are shown to be associated with LPS-induced IL-10 production. However, there is no association for the -819 polymorphism. Our results are in agreement with previous reports [15,34], but in contrast to the results reported by Keijsers and colleagues [36] and Rad and colleagues [37]. They showed that the A allele at -1082 and the T allele at -819 were associated with higher and lower IL-10 production, respectively. Similar to their effect on transcription, LPS-stimulating production of IL-10 by peripheral blood leukocytes is lowest in patients with combined genotype 2 ATA, which is significantly different compared with patients with genotype 0 ATA. The ATA haplotype has been demonstrated to have lowest transcriptional activity [19]. Our results further confirm the functionality of the IL-10 promoter SNPs in relation to IL-10 production. It also suggests that individual differences in IL-10 production in trauma patients might be at least in part related to genetic variations in the IL-10 promoter region.
###end p 51
###begin p 52
###xml 1307 1309 1307 1309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 1669 1671 1669 1671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 2354 2356 2354 2356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 2719 2721 2719 2721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 3128 3130 3128 3130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 3364 3366 3353 3355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
###xml 3367 3369 3356 3358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
###xml 242 250 <span type="species:ncbi:9606">patients</span>
###xml 497 504 <span type="species:ncbi:9606">patient</span>
###xml 531 539 <span type="species:ncbi:9606">patients</span>
###xml 826 834 <span type="species:ncbi:9606">patients</span>
###xml 1071 1079 <span type="species:ncbi:9606">patients</span>
###xml 1212 1220 <span type="species:ncbi:9606">patients</span>
###xml 1505 1513 <span type="species:ncbi:9606">Patients</span>
###xml 2164 2172 <span type="species:ncbi:9606">patients</span>
###xml 2326 2334 <span type="species:ncbi:9606">patients</span>
###xml 2373 2380 <span type="species:ncbi:9606">patient</span>
###xml 2497 2505 <span type="species:ncbi:9606">patients</span>
###xml 2884 2892 <span type="species:ncbi:9606">patients</span>
###xml 3433 3441 <span type="species:ncbi:9606">patients</span>
###xml 3745 3753 <span type="species:ncbi:9606">patients</span>
###xml 3784 3792 <span type="species:ncbi:9606">patients</span>
###xml 3954 3962 <span type="species:ncbi:9606">patients</span>
###xml 4088 4096 <span type="species:ncbi:9606">patients</span>
Given the functional significance of the -1082 and -592 polymorphisms and ATA haplotype, we further hypothesized that the IL-10 promoter polymorphisms would be important in influencing severity to the development of sepsis and MODS in trauma patients by changing the balance of pro-inflammatory and anti-inflammatory cytokines. There were no significant differences in age, gender ratio and ISS scores among the different genotype groups, which minimized the influence of interfering factors. The patient cohort consisted of young patients with a low background of coexisting morbidity. Similar to their association with IL-10 production, genetic variations at the three loci have a trend to be associated with lower risk of sepsis and MODS. However, only the -1082 polymorphism has statistical significance, showing that the patients with the A allele had significantly higher sepsis morbidity and a borderline significant increase in MODS scores. There are also significant differences in the frequencies of the allele and AA genotype at this polymorphic locus between patients with sepsis and non-sepsis. The finding of no significant difference in the GG genotype frequency might be due to a small number of patients carrying the GG genotype in the current study. Results from Stanilova and colleagues [22] also revealed that the AA genotype of the -1082 locus was associated with lower IL-10 production in LPS-, phytohemagglutinin- or pokeweed mitogen-stimulated healthy peripheral blood leukocytes. Patients with severe sepsis were shown to have a significant elevation of A allele frequency when compared with healthy controls. In addition, Gong and colleagues [21] further reported that the high IL-10-producing -1082 GG genotype was protective against organ failure and mortality in acute respiratory distress syndrome. It is increasingly recognized that the overall balance between pro-inflammatory and anti-inflammatory responses is important in the development of sepsis and MODS after trauma. Therefore, it is reasonable that lower IL-10-producing -1082 AA genotype might be used as a relevant risk estimate for organ dysfunction and sepsis in trauma patients. This is not consistent with the report by Schroeder and colleagues, which showed that the -592 polymorphism, but not -1082, was associated with MODS in patients with major trauma [23]. The different patient populations studied may explain this discrepancy. With respect to the combination effect, our results show that the patients with 2 ATA haplotypes have higher sepsis morbidity rates, but this lacks statistical significance, although it is significantly associated with lower IL-10 production. This is in accordance with previous reports [38]. It suggests that there is a lack of synergistic effect among the -1082, -819 and -592 polymorphisms in relation to the development of sepsis and MODS in trauma patients. Other pathogenic factors should be also considered when explaining the current results. One important factor is the polygenetic and multifactorial involvement in the pathogenesis of sepsis and multiple organ dysfunction after trauma [39]. In fact, there is increasing evidence indicating that genetic polymorphisms of other genes are associated with the occurrence of post-traumatic complications, such as IL-1beta, TNFalpha, heat shock protein 70, IFN-gamma and IL-18 [40,41]. The susceptibility to sepsis and organ dysfunction in trauma patients might be the result of a combination of numerous genetic polymorphisms. In addition, the relatively small sample size we recruited in this study might also affect our conclusions. Our sample, although being considered adequate by means of the Power and Sample Size program, just has a size of about 300 patients, among which only 147 and 160 patients had sepsis and MODS, respectively. Further studies are needed to confirm the clinical relevance of the IL-10 promoter polymorphisms in a larger cohort of trauma patients and to investigate the relation of these SNPs with other genetic polymorphisms in prediction of sepsis and outcome in trauma patients.
###end p 52
###begin title 53
Conclusions
###end title 53
###begin p 54
###xml 139 147 <span type="species:ncbi:9606">patients</span>
###xml 606 614 <span type="species:ncbi:9606">patients</span>
The present study investigated the clinical relevance of the genetic variations at positions -1082, -819 and -592 in the IL-10 promoter in patients with major trauma. These genetic variations are shown to affect IL-10 production after trauma, and to be associated with risk for the development of post-traumatic sepsis and MODS at different degrees. Further studies, both clinical and experimental, are therefore needed to confirm the significance of these findings and to investigate their synergistic effect with other genetic polymorphisms in relation to the development of sepsis and outcome in trauma patients.
###end p 54
###begin title 55
Key messages
###end title 55
###begin p 56
###xml 122 130 122 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo </italic>
* The -1082A and -592A alleles and ATA haplotype were significantly associated with lower IL-10 production in response to ex vivo LPS stimulation.
###end p 56
###begin p 57
###xml 97 105 <span type="species:ncbi:9606">patients</span>
* The -1082 polymorphism was closely associated with the development of sepsis, showing that the patients with the A allele had significantly higher sepsis morbidity.
###end p 57
###begin p 58
###xml 147 155 <span type="species:ncbi:9606">patients</span>
* There are no marked synergistic effects among the -1082, -819 and -592 polymorphisms in relation to the development of sepsis and MODS in trauma patients.
###end p 58
###begin title 59
Abbreviations
###end title 59
###begin p 60
CI: confidence interval; ELISA: enzyme-linked immunosorbent assay; IFN-gamma: interferon-gamma; IL-10: interleukin-10; ISS: Injury Severity Score; LPS: lipopolysaccharide; MODS: multiple organ dysfunction syndrome; OR: odds ratios; PCR: polymerase chain reaction; RFLP: restriction fragment length polymorphism; SNPs: single nucleotide polymorphisms; TNF-alpha: tumor necrosis factor alpha.
###end p 60
###begin title 61
Competing interests
###end title 61
###begin p 62
The authors declare that they have no competing interests.
###end p 62
###begin title 63
Authors' contributions
###end title 63
###begin p 64
LZ and WG were the main researchers for this study and co-contributed to write this manuscript. K-HC, D-PJ, L-YZ, D-YD and PH were involved in the collecting of blood samples and clinical data. QL and S-NH did the technical work. J-XJ planned the study, wrote the protocol and was involved in the genetic and clinical aspects of data analyses and revised the manuscript. All authors read and approved the final manuscript.
###end p 64
###begin title 65
Acknowledgements
###end title 65
###begin p 66
The authors thank the staff of the department of traumatic Surgery of Daping Hospital and Chongqing Emergency Medical Center for their clinical help and support. The present study was supported by the Major State Basic Research Development Program of China (No. 2005CB522602), and the National Funds for Outstanding Youth Scientists (30325040).
###end p 66
###begin article-title 67
An overview of research advances in road traffic trauma in China
###end article-title 67
###begin article-title 68
Posttraumatic stress and immune dissonance
###end article-title 68
###begin article-title 69
###xml 37 45 <span type="species:ncbi:9606">patients</span>
Predicting multiple organ failure in patients with severe trauma
###end article-title 69
###begin article-title 70
Systemic inflammation after trauma
###end article-title 70
###begin article-title 71
Genomic polymorphisms and sepsis
###end article-title 71
###begin article-title 72
Functional significance of gene polymorphisms in the promoter of myeloid differentiation-2
###end article-title 72
###begin article-title 73
Properties and functions of interleukin-10
###end article-title 73
###begin article-title 74
Interleukin-10: new perspectives on an old cytokine
###end article-title 74
###begin article-title 75
Role of endogenous interleukin-10 in local and distant organ injury after visceral ischemia-reperfusion
###end article-title 75
###begin article-title 76
###xml 99 107 <span type="species:ncbi:9606">patients</span>
Relationship of interleukin-10 plasma levels to severity of injury and clinical outcome in injured patients
###end article-title 76
###begin article-title 77
Early versus late onset of multiple organ failure is associated with differing patterns of plasma cytokine biomarker expression and outcome after severe trauma
###end article-title 77
###begin article-title 78
###xml 53 61 <span type="species:ncbi:9606">patients</span>
Molecular analysis of inflammatory markers in trauma patients at risk of postinjury complications
###end article-title 78
###begin article-title 79
Genetic influence on cytokine production and fatal meningococcal disease
###end article-title 79
###begin article-title 80
###xml 49 54 <span type="species:ncbi:10090">mouse</span>
Genetic contribution to the septic response in a mouse model
###end article-title 80
###begin article-title 81
An investigation of polymorphism in the interleukin-10 gene promoter
###end article-title 81
###begin article-title 82
TNF alpha and IL10 SNPs act together to predict disease behavior in Crohn's disease
###end article-title 82
###begin article-title 83
Interleukin-10-1082 promoter polymorphism is associated with schizophrenia in a Han Chinese sib-pair study
###end article-title 83
###begin article-title 84
###xml 40 48 <span type="species:ncbi:9606">patients</span>
###xml 54 71 <span type="species:ncbi:10407">hepatitis B virus</span>
Interleukin-10 promoter polymorphism in patients with hepatitis B virus infection or hepatocellular carcinomain Chinese Han ethnic population
###end article-title 84
###begin article-title 85
###xml 95 103 <span type="species:ncbi:9606">patients</span>
Interleukin-10 gene promoter polymorphisms and their protein production in peritoneal fluid in patients with endometriosis
###end article-title 85
###begin article-title 86
The association between promoter polymorphism of the interleukin-10 gene and Alzheimer's disease
###end article-title 86
###begin article-title 87
Interleukin-10 polymorphism in position - 1082 and acute respiratory distress syndrome
###end article-title 87
###begin article-title 88
Interleukin-10-1082 promoter polymorphism in association with cytokine production and sepsis susceptibility
###end article-title 88
###begin article-title 89
Association of interleukin-10 promoter polymorphism with the incidence of multiple organ dysfunction following major trauma: results of a prospective pilot study
###end article-title 89
###begin article-title 90
###xml 79 87 <span type="species:ncbi:9606">patients</span>
A polymorphism in the interleukin-10 promoter affects the course of disease in patients with clear-cell renal carcinoma
###end article-title 90
###begin article-title 91
Lack of association between cytokine gene polymorphisms and silicosis and pulmonary tuberculosis in Chinese iron miners
###end article-title 91
###begin article-title 92
The -1082 interleukin-10 polymorphism is associated with acute respiratory failure after major trauma: a prospective cohort study
###end article-title 92
###begin article-title 93
The Abbreviated Injury Scale. Barrington. Illinois: Association for the Advancement of Automotive Medicine
###end article-title 93
###begin article-title 94
Multiple organ dysfunction score: A reliable descriptor of a complex clinical outcome
###end article-title 94
###begin article-title 95
Power and Sample Size Program
###end article-title 95
###begin article-title 96
###xml 117 122 <span type="species:ncbi:9606">human</span>
Single nucleotide polymorphisms of cytokine genes are associated with fibrosis of the intrahepatic bile duct wall in human clonorchiasis
###end article-title 96
###begin article-title 97
IL10 and IL10 receptor gene variation and outcomes after unrelated and related hematopoietic cell transplantation
###end article-title 97
###begin article-title 98
Analysis of IL-10, IL-4 and TNF-a polymorphisms in drug-induced liver injury (DILI) and its outcome
###end article-title 98
###begin article-title 99
Problems of reporting genetic associations with complex outcomes
###end article-title 99
###begin article-title 100
Genetic influence of cytokine production and fatal meningococcal disease
###end article-title 100
###begin article-title 101
MOTIF Search
###end article-title 101
###begin article-title 102
IL10 polymorphisms in relation to production and rheumatoid arthritis
###end article-title 102
###begin article-title 103
###xml 125 144 <span type="species:ncbi:210">Helicobacter pylori</span>
Cytokine gene polymorphism influence mucosal cytokine expression, gastric inflammation and host specific colonization during Helicobacter pylori infection
###end article-title 103
###begin article-title 104
Genetic variation in proinflammatory and anti-inflammatory cytokine production in multiple organ dysfunction syndrome
###end article-title 104
###begin article-title 105
The genetic predisposition to adverse outcome after trauma
###end article-title 105
###begin article-title 106
Effects of haplotypes in the interleukin 1 beta promoter on lipopolysacchride-induced interleukin 1 beta expression
###end article-title 106
###begin article-title 107
Genentic predisposition for a compromised immune system after multiple trauma
###end article-title 107

